DexCom (DXCM) Tops Q2 EPS by 3c; offers guidance
Tweet
Share
E-mailGet Alerts DXCM Hot Sheet
Price: $91.69 +1.63%
Financial Fact:
Selling, general and administrative: 75.7M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Selling, general and administrative: 75.7M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
DexCom (NASDAQ: DXCM) reported Q2 EPS of $0.48, $0.03 better than the analyst estimate of $0.45. Revenue for the quarter came in at $1.16 billion versus the consensus estimate of $1.12 billion.
GUIDANCE:
DexCom sees FY2025 revenue of $4.6-4.625 billion, versus the consensus of $4.611 billion.
For earnings history and earnings-related data on DexCom (DXCM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nscale targets up to $3B in US IPO as soon as September - Bloomberg
- Flowers Foods (FLO) Misses Q2 EPS by 3c; Offers Guidance
- Beike (BEKE) PT Raised to $23 at Morgan Stanley
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
